SlideShare una empresa de Scribd logo
1 de 10
Descargar para leer sin conexión
Dr.Mohd Farooq Naqshbandi
M.D, Ph.D
Non alcoholic Fatty
Liver Disease:
Nonalcoholic fatty liver disease (NAFLD)
is a clinicopathological syndrome caused
by genetic, environmental, and metabolic
stress-related factors and clinically
manifested as fat accumulation in
hepatocytes. Specifically, this
accumulation exceeds 5% of hepatic wet
weight, or changes in the fatty content
took place in over 1/3 of hepatocytes per
unit area even though the over
consumption of alcohol can be expressly
excluded.
In recent years, with the improvement
of the living standards, lifestyle change,
aging of the population, and rise in
obesity, NAFLD incidence remarkably
increased in world
making it an increasingly important
chronic noninfectious with global
prevalence of 30%
No records are available regarding NAFLD in the Ayush, but according to the
symptoms and signs, it may be associated to what it is described as “lump at the left
hypochondrium, y,” “accumulation, c,” “phlegmatic mass, h,” “hypochondriac
pain, . NAFLD is induced due to 3 reasons:
1. Improper diet,
2. Emotional disorder, and
3. Maladjustment in work and rest .
NAFLD is caused by multiple factors including:
(1)Insulin Resistance.
It means that the sensitivity of the body to the produced insulin is reduced due to
various causes. To maintain a stable blood sugar level, the body secretes even more
insulin to compensate, resulting in hyperinsulinemia leading to an increase in
glycolysis to produce more fatty acids. Insulin resistance leads to an increase in free
fatty acids due to its impact on lipid metabolism, which is beyond hepatic metabolic
ability, resulting in excessive fatty acids accumulated in the liver. In addition, the
secretion of very-low-density lipoprotein decreases so that TG increases.
(2) Lipid Metabolism Disorder. It synthesis and secretion of triglyceride
transfer protein and apolipoprotein decrease due to various causes. Triglycerides
transferred by the liver are reduced; thus, they accumulate in the liver, resulting in
NAFLD.
(3) Mitochondrial Dysfunction. Mitochondria play a central role in complex processes,
including the generation of energy and reactive oxygen species (ROS), maintaining
calcium homeostasis, and adjusting apoptosis and lipid metabolism . It has been
demonstrated that mitochondrial dysfunction is an important mechanism of NAFLD
and its aggravation, in which the following mechanisms may play a role . (1)
mitochondrial DNA damage; (2)
disorders of energy metabolism; (3) oxidative stress and lipid peroxidation; (4)
mitochondria-mediated hepatocellular apoptosis; (5) disorders of fatty acid
metabolism; and (6) abnormal mitophagy. 2us, strategies to prevent mitochondrial
(3) Mitochondrial Dysfunction.
Mitochondria play a central role in complex processes,
including the generation of energy and reactive oxygen
species (ROS), maintaining calcium homeostasis, and
adjusting apoptosis and lipid metabolism . It has been
demonstrated that mitochondrial dysfunction is an important
mechanism of NAFLD and its aggravation, in which the
following mechanisms may play a role .
(1) mitochondrial DNA damage
(2)Disorders of energy metabolism;
(3) oxidative stress and lipid peroxidation;
(4) mitochondria-mediated hepatocellular apoptosis;
(5) disorders of fatty acid metabolism; and
(6) abnormal mitophagy.
(4) Oxidative Stress.
Oxidative stress occurs due to various causes.
When a large amount of fat is stored in the liver,
oxidative stress is significantly increased and energy
is provided by excessive fatty acids. Long term
oxidative stress stimulates the liver, which may
lead to nonalcoholic steatohepatitis (NASH) and
cirrhosis . Oxidative stress is considered as the most
important mechanism causing damage to the
liver in the “two-hit” hypothesis. The produced
reactive oxygen species (ROS) increase damage to
oxidative phosphorylation uncoupling and cell
membrane leading to a vicious cycle that aggravates
liver inflammation
Oxidative stress mechanism in promote fatty liver disease induced by high-fat diet is as
ollows:
(1) ROS formed by oxidative stress can combine with biological membrane
phospholipids, enzymes, membrane receptor polyunsaturated fatty acid side chains, and
macromolecules like nucleic acid, resulting in lipid peroxidation. Resulted lipid peroxides
can increase endogenous ROS and toxicity and inhibit the antioxidant system. Lipid
peroxidation can promote the synthesis and release of malondialdehyde (MDA) and B-
hydroxylated nonene. Oxidative stress, lipid peroxidation, and mitochondrial damage
urther increase ROS/RNS production and accelerate and worsen fatty degeneration
resulting in NASH and fibrosis .
2) Lipids accumulate in liver cells. TNF-α is induced because oxidative stress and lipid
peroxidation stimulate IKKβ/NF-κB inflammatory pathway. Then inflammatory factors
L-1 and IL-6 initiate and promote inflammation [37] result in positive feedback to
ncrease IKKβ activity, forming a vicious IKKβ/NF-κB cycle. Such waterfall effect
ncreases insulin signal transduction disorders and ultimately leads to intrahepatic insulin
resistance and abnormal expression of PKB .
(3) The molecule in the insulin signal pathway, PKB is very sensitive to oxygen free
radicals and its activity can be regulated by ROS. Free radicals can destroy its
phosphorylation sites and affect its activity . A study on co-antioxidant containing GSH
on oxidative stress in T2DM rats based on microsomal lipid peroxidation model showed
hat the expression of P-PKB/ PKB in liver and muscle tissues of these rats treated with
antioxidant was significantly higher than that of normal control group. therefore,
oxidative stress may be one of the initial factors that cause abnormal expression of PKB in
he liver.
NFALD.pptx
NAFLD can be prevented by following a scientific and reasonable dietary regimen,
correcting poor dietary habits, reducing alcohol intake or quitting drinking, doing a
moderate amount of aerobic exercise,. NAFLD treatment is a long-term
comprehensive procedure, and the specific measures are as follows
(i) adopting a healthy lifestyle, including balanced diet and maintaining a positive
attitude;.
(ii) Reducing causes and inducements, including weight control and waistline
reduction;
(iii) preventing and treating metabolic disorders, such as taking antiplatelet, lipid-
regulating, hypoglycemic, and antihypertensive drugs rationally in accordance
with healthy blood viscosity, blood sugar, blood fat, blood pressure, and insulin
resistance.
(iv) Using anti inflammatory and liver-protecting drugs to treat NASH and
progressive hepatic fibrosis, to reduce liver disability and mortality. Moreover,
anti-inflammatory and liver-protecting drugs.

Más contenido relacionado

Similar a NFALD.pptx

NAFLD in Children
NAFLD in ChildrenNAFLD in Children
NAFLD in ChildrenCSN Vittal
 
Mitochondria in non alcoholic fatty liver disease
Mitochondria in non alcoholic fatty liver diseaseMitochondria in non alcoholic fatty liver disease
Mitochondria in non alcoholic fatty liver diseaseDindiDhanunjai
 
Neuroendocrine response In trauma and sepsis.pptx
Neuroendocrine response In trauma and sepsis.pptxNeuroendocrine response In trauma and sepsis.pptx
Neuroendocrine response In trauma and sepsis.pptxBiniam24
 
Resveratrol, Caloric Restriction and Longevity in Human Mitochondrial Dysfunc...
Resveratrol, Caloric Restriction and Longevity in Human Mitochondrial Dysfunc...Resveratrol, Caloric Restriction and Longevity in Human Mitochondrial Dysfunc...
Resveratrol, Caloric Restriction and Longevity in Human Mitochondrial Dysfunc...Ayetenew Abita Desa
 
Biochemical Study on Endothelial Nitric Oxide Gene Polymorphism in Fatty Live...
Biochemical Study on Endothelial Nitric Oxide Gene Polymorphism in Fatty Live...Biochemical Study on Endothelial Nitric Oxide Gene Polymorphism in Fatty Live...
Biochemical Study on Endothelial Nitric Oxide Gene Polymorphism in Fatty Live...iosrjce
 
Metabolic syndrome & its complications
Metabolic syndrome & its complicationsMetabolic syndrome & its complications
Metabolic syndrome & its complicationsPradeep Singh Narwat
 
41392_2022_Article_1149.pdf
41392_2022_Article_1149.pdf41392_2022_Article_1149.pdf
41392_2022_Article_1149.pdfRodrigoDalia1
 
Alcoholic liver disease_patho_RDP
Alcoholic liver disease_patho_RDPAlcoholic liver disease_patho_RDP
Alcoholic liver disease_patho_RDPrishi2789
 
Nonalcoholic Fatty Liver Disease Essay
Nonalcoholic Fatty Liver Disease EssayNonalcoholic Fatty Liver Disease Essay
Nonalcoholic Fatty Liver Disease EssayCindy Turner
 
Concept note presentation.pptx
Concept note presentation.pptxConcept note presentation.pptx
Concept note presentation.pptxhailuhenock
 
Nutritional diseases (Obesity and starvation)
Nutritional diseases (Obesity and starvation)Nutritional diseases (Obesity and starvation)
Nutritional diseases (Obesity and starvation)Koppala RVS Chaitanya
 
Proinflammation Research Paper
Proinflammation Research PaperProinflammation Research Paper
Proinflammation Research PaperMelissa Moore
 
Dysbiosis and NAFLD.pptx
Dysbiosis and NAFLD.pptxDysbiosis and NAFLD.pptx
Dysbiosis and NAFLD.pptxMohamed Wifi
 
Nutrient sensing and metabolic disturbances
Nutrient sensing and metabolic disturbancesNutrient sensing and metabolic disturbances
Nutrient sensing and metabolic disturbanceshelix1661
 
Antihyperlipidimic drug therapy-current and noval approaches.pptx
Antihyperlipidimic drug therapy-current and noval approaches.pptxAntihyperlipidimic drug therapy-current and noval approaches.pptx
Antihyperlipidimic drug therapy-current and noval approaches.pptxMohammedObaidMohiudd
 

Similar a NFALD.pptx (20)

Role of oxidant_alteration_of_biomolecules_in_diabetes_and_other_associated_d...
Role of oxidant_alteration_of_biomolecules_in_diabetes_and_other_associated_d...Role of oxidant_alteration_of_biomolecules_in_diabetes_and_other_associated_d...
Role of oxidant_alteration_of_biomolecules_in_diabetes_and_other_associated_d...
 
Alcohol
AlcoholAlcohol
Alcohol
 
NAFLD in Children
NAFLD in ChildrenNAFLD in Children
NAFLD in Children
 
Metabolic Syndrome.pptx
Metabolic Syndrome.pptxMetabolic Syndrome.pptx
Metabolic Syndrome.pptx
 
Mitochondria in non alcoholic fatty liver disease
Mitochondria in non alcoholic fatty liver diseaseMitochondria in non alcoholic fatty liver disease
Mitochondria in non alcoholic fatty liver disease
 
Neuroendocrine response In trauma and sepsis.pptx
Neuroendocrine response In trauma and sepsis.pptxNeuroendocrine response In trauma and sepsis.pptx
Neuroendocrine response In trauma and sepsis.pptx
 
Resveratrol, Caloric Restriction and Longevity in Human Mitochondrial Dysfunc...
Resveratrol, Caloric Restriction and Longevity in Human Mitochondrial Dysfunc...Resveratrol, Caloric Restriction and Longevity in Human Mitochondrial Dysfunc...
Resveratrol, Caloric Restriction and Longevity in Human Mitochondrial Dysfunc...
 
Curcumin
CurcuminCurcumin
Curcumin
 
Biochemical Study on Endothelial Nitric Oxide Gene Polymorphism in Fatty Live...
Biochemical Study on Endothelial Nitric Oxide Gene Polymorphism in Fatty Live...Biochemical Study on Endothelial Nitric Oxide Gene Polymorphism in Fatty Live...
Biochemical Study on Endothelial Nitric Oxide Gene Polymorphism in Fatty Live...
 
Metabolic syndrome & its complications
Metabolic syndrome & its complicationsMetabolic syndrome & its complications
Metabolic syndrome & its complications
 
41392_2022_Article_1149.pdf
41392_2022_Article_1149.pdf41392_2022_Article_1149.pdf
41392_2022_Article_1149.pdf
 
Alcoholic liver disease_patho_RDP
Alcoholic liver disease_patho_RDPAlcoholic liver disease_patho_RDP
Alcoholic liver disease_patho_RDP
 
Nonalcoholic Fatty Liver Disease Essay
Nonalcoholic Fatty Liver Disease EssayNonalcoholic Fatty Liver Disease Essay
Nonalcoholic Fatty Liver Disease Essay
 
Concept note presentation.pptx
Concept note presentation.pptxConcept note presentation.pptx
Concept note presentation.pptx
 
Nutritional diseases (Obesity and starvation)
Nutritional diseases (Obesity and starvation)Nutritional diseases (Obesity and starvation)
Nutritional diseases (Obesity and starvation)
 
Proinflammation Research Paper
Proinflammation Research PaperProinflammation Research Paper
Proinflammation Research Paper
 
ADIPONECTIN.pptx
ADIPONECTIN.pptxADIPONECTIN.pptx
ADIPONECTIN.pptx
 
Dysbiosis and NAFLD.pptx
Dysbiosis and NAFLD.pptxDysbiosis and NAFLD.pptx
Dysbiosis and NAFLD.pptx
 
Nutrient sensing and metabolic disturbances
Nutrient sensing and metabolic disturbancesNutrient sensing and metabolic disturbances
Nutrient sensing and metabolic disturbances
 
Antihyperlipidimic drug therapy-current and noval approaches.pptx
Antihyperlipidimic drug therapy-current and noval approaches.pptxAntihyperlipidimic drug therapy-current and noval approaches.pptx
Antihyperlipidimic drug therapy-current and noval approaches.pptx
 

Más de GovernmentUnaniHospi

Más de GovernmentUnaniHospi (7)

ISM in India.pptx
ISM in India.pptxISM in India.pptx
ISM in India.pptx
 
OVERVIEW OF TRADITIONAL MEDICINES.pptx
OVERVIEW OF TRADITIONAL MEDICINES.pptxOVERVIEW OF TRADITIONAL MEDICINES.pptx
OVERVIEW OF TRADITIONAL MEDICINES.pptx
 
OVERVIEW OF TRADITIONAL MEDICINES.pptx
OVERVIEW OF TRADITIONAL MEDICINES.pptxOVERVIEW OF TRADITIONAL MEDICINES.pptx
OVERVIEW OF TRADITIONAL MEDICINES.pptx
 
MUSCULOSKELTON DISORDERS.pptx
MUSCULOSKELTON DISORDERS.pptxMUSCULOSKELTON DISORDERS.pptx
MUSCULOSKELTON DISORDERS.pptx
 
NEPHROLIATHISIS.pptx
NEPHROLIATHISIS.pptxNEPHROLIATHISIS.pptx
NEPHROLIATHISIS.pptx
 
hypertension final (4).ppt
hypertension final (4).ppthypertension final (4).ppt
hypertension final (4).ppt
 
pharmacists training.pptx
pharmacists training.pptxpharmacists training.pptx
pharmacists training.pptx
 

Último

EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 

Último (20)

EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 

NFALD.pptx

  • 1. Dr.Mohd Farooq Naqshbandi M.D, Ph.D Non alcoholic Fatty Liver Disease:
  • 2. Nonalcoholic fatty liver disease (NAFLD) is a clinicopathological syndrome caused by genetic, environmental, and metabolic stress-related factors and clinically manifested as fat accumulation in hepatocytes. Specifically, this accumulation exceeds 5% of hepatic wet weight, or changes in the fatty content took place in over 1/3 of hepatocytes per unit area even though the over consumption of alcohol can be expressly excluded.
  • 3. In recent years, with the improvement of the living standards, lifestyle change, aging of the population, and rise in obesity, NAFLD incidence remarkably increased in world making it an increasingly important chronic noninfectious with global prevalence of 30%
  • 4. No records are available regarding NAFLD in the Ayush, but according to the symptoms and signs, it may be associated to what it is described as “lump at the left hypochondrium, y,” “accumulation, c,” “phlegmatic mass, h,” “hypochondriac pain, . NAFLD is induced due to 3 reasons: 1. Improper diet, 2. Emotional disorder, and 3. Maladjustment in work and rest .
  • 5. NAFLD is caused by multiple factors including: (1)Insulin Resistance. It means that the sensitivity of the body to the produced insulin is reduced due to various causes. To maintain a stable blood sugar level, the body secretes even more insulin to compensate, resulting in hyperinsulinemia leading to an increase in glycolysis to produce more fatty acids. Insulin resistance leads to an increase in free fatty acids due to its impact on lipid metabolism, which is beyond hepatic metabolic ability, resulting in excessive fatty acids accumulated in the liver. In addition, the secretion of very-low-density lipoprotein decreases so that TG increases. (2) Lipid Metabolism Disorder. It synthesis and secretion of triglyceride transfer protein and apolipoprotein decrease due to various causes. Triglycerides transferred by the liver are reduced; thus, they accumulate in the liver, resulting in NAFLD. (3) Mitochondrial Dysfunction. Mitochondria play a central role in complex processes, including the generation of energy and reactive oxygen species (ROS), maintaining calcium homeostasis, and adjusting apoptosis and lipid metabolism . It has been demonstrated that mitochondrial dysfunction is an important mechanism of NAFLD and its aggravation, in which the following mechanisms may play a role . (1) mitochondrial DNA damage; (2) disorders of energy metabolism; (3) oxidative stress and lipid peroxidation; (4) mitochondria-mediated hepatocellular apoptosis; (5) disorders of fatty acid metabolism; and (6) abnormal mitophagy. 2us, strategies to prevent mitochondrial
  • 6. (3) Mitochondrial Dysfunction. Mitochondria play a central role in complex processes, including the generation of energy and reactive oxygen species (ROS), maintaining calcium homeostasis, and adjusting apoptosis and lipid metabolism . It has been demonstrated that mitochondrial dysfunction is an important mechanism of NAFLD and its aggravation, in which the following mechanisms may play a role . (1) mitochondrial DNA damage (2)Disorders of energy metabolism; (3) oxidative stress and lipid peroxidation; (4) mitochondria-mediated hepatocellular apoptosis; (5) disorders of fatty acid metabolism; and (6) abnormal mitophagy.
  • 7. (4) Oxidative Stress. Oxidative stress occurs due to various causes. When a large amount of fat is stored in the liver, oxidative stress is significantly increased and energy is provided by excessive fatty acids. Long term oxidative stress stimulates the liver, which may lead to nonalcoholic steatohepatitis (NASH) and cirrhosis . Oxidative stress is considered as the most important mechanism causing damage to the liver in the “two-hit” hypothesis. The produced reactive oxygen species (ROS) increase damage to oxidative phosphorylation uncoupling and cell membrane leading to a vicious cycle that aggravates liver inflammation
  • 8. Oxidative stress mechanism in promote fatty liver disease induced by high-fat diet is as ollows: (1) ROS formed by oxidative stress can combine with biological membrane phospholipids, enzymes, membrane receptor polyunsaturated fatty acid side chains, and macromolecules like nucleic acid, resulting in lipid peroxidation. Resulted lipid peroxides can increase endogenous ROS and toxicity and inhibit the antioxidant system. Lipid peroxidation can promote the synthesis and release of malondialdehyde (MDA) and B- hydroxylated nonene. Oxidative stress, lipid peroxidation, and mitochondrial damage urther increase ROS/RNS production and accelerate and worsen fatty degeneration resulting in NASH and fibrosis . 2) Lipids accumulate in liver cells. TNF-α is induced because oxidative stress and lipid peroxidation stimulate IKKβ/NF-κB inflammatory pathway. Then inflammatory factors L-1 and IL-6 initiate and promote inflammation [37] result in positive feedback to ncrease IKKβ activity, forming a vicious IKKβ/NF-κB cycle. Such waterfall effect ncreases insulin signal transduction disorders and ultimately leads to intrahepatic insulin resistance and abnormal expression of PKB . (3) The molecule in the insulin signal pathway, PKB is very sensitive to oxygen free radicals and its activity can be regulated by ROS. Free radicals can destroy its phosphorylation sites and affect its activity . A study on co-antioxidant containing GSH on oxidative stress in T2DM rats based on microsomal lipid peroxidation model showed hat the expression of P-PKB/ PKB in liver and muscle tissues of these rats treated with antioxidant was significantly higher than that of normal control group. therefore, oxidative stress may be one of the initial factors that cause abnormal expression of PKB in he liver.
  • 10. NAFLD can be prevented by following a scientific and reasonable dietary regimen, correcting poor dietary habits, reducing alcohol intake or quitting drinking, doing a moderate amount of aerobic exercise,. NAFLD treatment is a long-term comprehensive procedure, and the specific measures are as follows (i) adopting a healthy lifestyle, including balanced diet and maintaining a positive attitude;. (ii) Reducing causes and inducements, including weight control and waistline reduction; (iii) preventing and treating metabolic disorders, such as taking antiplatelet, lipid- regulating, hypoglycemic, and antihypertensive drugs rationally in accordance with healthy blood viscosity, blood sugar, blood fat, blood pressure, and insulin resistance. (iv) Using anti inflammatory and liver-protecting drugs to treat NASH and progressive hepatic fibrosis, to reduce liver disability and mortality. Moreover, anti-inflammatory and liver-protecting drugs.